As the recognized role of autoantibodies in multiple gastrointestinal dysmotility disorders, including anti-GAD65 in diseases implicated in GERD [26, 27], continues to increase, further research may shed light on a potential pathophysiology that is common in both central and autonomic nervous system dysfunctions of SPS. This evidence concerns the gene GAD2 and stiff-person syndrome.